Return to homepagePandemic Pact

Discovery and Translational Sciences

Grant number: INV-040931

Grant search

Key facts

  • Disease

    COVID-19, Severe Acute Respiratory Syndrome (SARS), Middle East respiratory syndrome coronavirus (MERS)

  • Start & end year

    2022
    2022

  • Known Financial Commitments (USD)

    $226,870

  • Funder

    Gates Foundation

  • Research Location

    United Kingdom

  • Lead Research Institution

    Collaborative Community against Coronavirus (CIC)

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

to validate 2 active series of antiviral compounds with pan coronavirus potential